BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 16800414)

  • 1. Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis.
    Spangler DL; Brunton S
    South Med J; 2006 Jun; 99(6):593-9. PubMed ID: 16800414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of seasonal allergic rhinitis: comparative efficacy of the newer-generation prescription antihistamines.
    Conboy-Ellis K
    J Am Acad Nurse Pract; 2005 Aug; 17(8):295-301. PubMed ID: 16045589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
    Glass DJ; Harper AS
    BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer antihistamines.
    Med Lett Drugs Ther; 2001 Apr; 43(1103):35. PubMed ID: 11331439
    [No Abstract]   [Full Text] [Related]  

  • 7. Selecting the optimal oral antihistamine for patients with allergic rhinitis.
    Lehman JM; Blaiss MS
    Drugs; 2006; 66(18):2309-19. PubMed ID: 17181374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset of action for the relief of allergic rhinitis symptoms with second-generation antihistamines.
    Greisner WA
    Allergy Asthma Proc; 2004; 25(2):81-3. PubMed ID: 15176489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of second generation antihistamines.
    Philpot EE
    Allergy Asthma Proc; 2000; 21(1):15-20. PubMed ID: 10748947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
    Stübner P; Zieglmayer R; Horak F
    Curr Med Res Opin; 2004 Jun; 20(6):891-902. PubMed ID: 15200748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
    Van Cauwenberge P; Juniper EF
    Clin Exp Allergy; 2000 Jun; 30(6):891-9. PubMed ID: 10848909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.
    Phan H; Moeller ML; Nahata MC
    Drugs; 2009; 69(18):2541-76. PubMed ID: 19943707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihistaminics. Side effects also after raising dosage at the placebo level].
    MMW Fortschr Med; 2003 May; 145(22):50-1. PubMed ID: 12866280
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical aspects of anti-inflammatory action of antihistamines].
    Grzelewska-Rzymowska I
    Pol Merkur Lekarski; 2003 Jun; 14(84):634-8. PubMed ID: 14524290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
    Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
    Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE; Schenkel EJ; Mansfield LE;
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
    MMW Fortschr Med; 2003 May; 145(22):51. PubMed ID: 12866281
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
    Raphael GD; Angello JT; Wu MM; Druce HM
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.